Home LiteratureArticle Details
PMID: 16628555 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't

Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection.

Pediatric blood & cancer ·Vol. 47 ·No. 3 ·2006-09-00 ·Pages 327-9

Sastry J, Kakakios A, Tugwell H, Shaw PJ

Abstract

Chronic granulomatous disease (CGD) is a rare disorder characterized by recurrent infections, often resulting in impaired quality of life and death. Allogeneic BMT provides a definitive cure for CGD, but carries a significant risk of mortality and morbidity. The risk is higher for those who have invasive fungal infection prior to transplant. Reduced intensity conditioning (RIC) is associated with less toxicity from the conditioning agents and may provide an alternative option for all non-malignant diseases. We report a case of successful allogeneic BMT after RIC for a case of X-linked CGD complicated by severe invasive aspergillosis (IA).

MeSH Terms
Antifungal Agents/therapeutic use Aspergillosis/complications,drug therapy Bone Marrow Transplantation Child Chronic Disease Granulomatous Disease, Chronic/complications,diagnosis,therapy Humans Male Prognosis Recurrence Transplantation Conditioning/methods Transplantation, Homologous Treatment Outcome
Chemicals
Antifungal Agents
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Sastry Jairam
Oncology Unit, The Children's Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia.
Kakakios Alyson
Tugwell Heidi
Shaw Peter J
Article Info
Journal
Pediatric blood & cancer
Abbr.
Pediatr Blood Cancer
ISSN
1545-5009
Published
2006-09-00
Pages
327-9
Language
English
Region
United States
NLM ID
101186624
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com